Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies.

Autor:	Tareen K; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. Electronic address: tkinza@med.umich.edu., Clifton EG; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA., Perumalswami P; Gastroenterology Section, Veterans Affairs, Ann Arbor Healthcare System, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Mellinger JL; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Winder GS; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Department of Surgery, University of Michigan, Ann Arbor, MI, USA; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Jazyk:	angličtina
Zdroj:	Clinics in liver disease [Clin Liver Dis] 2024 Nov; Vol. 28 (4), pp. 761-778.
DOI:	10.1016/j.cld.2024.06.011
Abstrakt:	The prevalence of alcohol use disorder (AUD) has significantly increased over the last decade, leading to an increase in alcohol-associated liver disease (ALD) rates worldwide. Despite this prominence, AUD in ALD remains undertreated and carries significant implications in the progression to end-stage ALD and increased mortality. In efforts to bridge this gap, interprofessional and integrated AUD treatment is necessary for patients with ALD to ensure early detection and an appropriately targeted level of care. Although pharmacotherapy, psychotherapy, and psychosocial interventions independently play a role in treating AUD, a combination of these evidence-based modalities often results in lasting change. Competing Interests: Disclosure None of the authors report any conflicts of interest. (Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu